Veeva Systems Inc  

(Public, NYSE:VEEV)   Watch this stock  
Find more results for Mark S. Wallach�
25.46
+0.11 (0.43%)
Mar 27 - Close
NYSE real-time data - Disclaimer
Currency in USD
Range 25.01 - 25.63
52 week 17.11 - 33.66
Open 25.24
Vol / Avg. 572,811.00/2.15M
Mkt cap 3.31B
P/E 89.22
Div/yield     -
EPS 0.29
Shares 58.48M
Beta     -
Inst. own 100%
Jun 4, 2015
Veeva Systems Inc Annual Shareholders Meeting (Estimated) - 4:00PM EDT - Add to calendar
May 27, 2015
Q1 2016 Veeva Systems Inc Earnings Release (Estimated) - 4:00PM EDT - Add to calendar
Mar 4, 2015
Veeva Systems Inc at Morgan Stanley Technology, Media & Telecom Conference
Mar 4, 2015
Veeva Systems Inc at Pacific Crest Emerging Technology Summit - Webcast
Mar 3, 2015
Q4 2015 Veeva Systems Inc Earnings Call
Mar 3, 2015
Q4 2015 Veeva Systems Inc Earnings Release
Jan 15, 2015
Veeva Systems Inc at JPMorgan Healthcare Conference Q&A session
Jan 15, 2015
Veeva Systems Inc at JPMorgan Healthcare Conference
More events from DailyFinance »    

Key stats and ratios

Q1 (Jan '15) 2015
Net profit margin 15.32% 12.89%
Operating margin 23.77% 22.34%
EBITD margin - 23.59%
Return on average assets 10.30% 8.82%
Return on average equity 13.57% 11.76%
Employees 887 -
CDP Score - -

Address

Suite 210, 4637 Chabot Drive
PLEASANTON, CA 94588
United States - Map
+1-925-4526500 (Phone)
+1-925-4526504 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money

Description

Veeva Systems Inc. (Veeva) which provides industry-specific, cloud-based software solutions for the life sciences industry. Veeva delivers industry-specific cloud-based solutions including data, software, and services to the global life sciences industry. The Company's solutions enable pharmaceutical and other life sciences companies. As of January 31, 2013, it served 51, 95 and 134 life sciences customers, respectively. As of August 31, 2013, it served approximately 170 life sciences customers, including 33 of the 50 largest global pharmaceutical companies. The Company's solutions have been implemented in over 75 countries.

Officers and directors

Gordon Ritter Chairman of the Board
Age: 49
Bio & Compensation  - Reuters
Matthew J. Wallach President, Co-Founder
Age: 41
Bio & Compensation  - Reuters
Peter P. Gassner Chief Executive Officer, Founder, Director
Age: 49
Bio & Compensation  - Reuters
TIMOTHY S CABRAL Chief Financial Officer
Age: 46
Bio & Compensation  - Reuters
Josh Faddis Vice President, General Counsel, Corporate Secretary
Age: 42
Bio & Compensation  - Reuters
Paul J. Sekhri Director
Age: 56
Bio & Compensation  - Reuters
Mark Armenante Independent Director
Age: 61
Bio & Compensation  - Reuters
Ronald E.F. Codd Independent Director
Age: 58
Bio & Compensation  - Reuters